Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: Effect of various additives

Chemical and Pharmaceutical Bulletin

Volumn 58, Issue 2, 2010, Pages 230-233

  Kim, Min Soo ^a   Kim, Jeong Soo ^a   Hwang, Sung Joo ^a  

^a Chungnam National University   (South Korea)

Author keywords

Additive; Cilostazol; Micronization; Poorly water soluble drug; Supercritical fluid

Indexed keywords

CARBON DIOXIDE; CILOSTAZOL; DICHLOROMETHANE; GELUCIRE; POLOXAMER; TOCOFERSOLAN;

ARTICLE; CONTACT ANGLE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; INFRARED SPECTROSCOPY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; SOLID STATE; SUPERCRITICAL FLUID EXTRACTION; SURFACE PROPERTY; WETTABILITY; X RAY DIFFRACTION;

CALORIMETRY, DIFFERENTIAL SCANNING; CARBON DIOXIDE; DRUG COMPOUNDING; EXCIPIENTS; PARTICLE SIZE; POWDER DIFFRACTION; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TETRAZOLES; WETTABILITY; X-RAY DIFFRACTION;

EID: 76149107174     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.58.230     Document Type: Article

References (25)

1. Vemavarapu C., Mollan M. J., Lodava M., Needham T. E., Int. J. Pharm., 292, 1-16 (2005).
2. Subramaniam B., Rajewski R. A., Snavely K., J. Pharm. Sci., 86, 885-890 (1997).
3. Dehghani F., Foster N.R., Curr. Opin. Solid State Mater. Sci., 7, 363-369 (2003).
4. Pasquali I., Bettini R., Giordano F., Eur. J. Pharm. Sci., 27, 299-310 (2006).
5. Park H. J., Kim M.-S., Lee S., Kim J.-S., Woo J.-S., Park J.-S., Hwang S.-J., Int. J. Pharm., 328, 152-160 (2007).
6. Jun S. W., Kim M.-S., Kim J.-S., Park H. J., Lee S., Woo J.-S., Hwang S.-J., Eur. J. Pharm. Biopharm., 66, 413-421 (2007).
7. Lee S., Nam K., Kim M.-S., Jun S. W., Park J.-S., Woo J. S., Hwang S.-J., Arch. Pharm. Res., 28, 866-874 (2005).
8. Reverchon E., J. Supercrit. Fluids, 15, 1-21 (1999).
9. Jung J., Perrut M., J. Supercrit. Fluids, 20, 179-219 (2001).
10. Perrut M., Jung J., Leboeuf F., Int. J. Pharm., 288, 3-10 (2005).
11. Perrut M., Jung J., Leboeuf F., Int. J. Pharm., 288, 11-16 (2005).
12. Senčar-Božič P., Srčič S., Knez Ž ., Kerč J., Int. J. Pharm., 148, 123-130 (1997).
13. Van Nijlen T., Brennan K., Van den Mooter G., Blaton N., Kinget R., Augustijns P., Int. J. Pharm., 254, 173-181 (2003).
14. Meure L. A., Warwick B., Dehgani F., Regtop H. L., Foster N. R., Ind. Eng. Chem. Res., 43, 1103-1112 (2004).
15. Jun S. W., Kim M.-S., Jo G. H., Lee S., Park J.-S., Woo J. S., Hwang S.-J., J. Pharm. Pharmacol., 57, 1529-1537 (2005).
16. Won D.-H., Kim M.-S., Lee S., Park J.-S., Hwang S.-J., Int. J. Pharm., 301, 199-208 (2005).
17. Majerik V., Charbit G., Badens E., Horváth G., Szokonya L., Bosc N., Teillaud E., J. Supercrit. Fluids, 40, 101-110 (2007).
18. Jarmer D. J., Lengsfeld C. S., Anseth K. S., Randolph T. W., J. Pharm. Sci., 94, 2688-2702 (2005).
19. Kim M.-S., Lee S., Park J.-S., Woo J.-S., Hwang S.-J., Powder Technol., 177, 64-70 (2008).
20. Cullity B. D., "Elements of X-ray Diffraction," 2nd ed., Addison-Wesley Publishing, Massachusetts, 1978.
21. Marshall P. V., York P., Int. J. Pharm., 55, 257-263 (1989).
22. Nokhodchi A., Bolourtchian N., Dinarvand R., Int. J. Pharm., 250, 85-97 (2003).
23. Stowell G. W., Behme R. J., Denton S. M., Pfeiffer I., Sancilio F. D., Whittall L. B., Whittle R. R., J. Pharm. Sci., 91, 2481-2488 (2002).
24. Vippagunta S. R., Brittain H. G., Grant D. J. W., Adv. Drug Deliv. Rev., 48, 3-26 (2001).
25. ICH, Fed. Regist., 68, 64352-64353 (1997).